The 'Dispatched' Podcast - Episode 1, Series 5

This is a preview of subscriber content

Subscribe now to continue reading.

In the first 2026 episode of Dispatched, we discuss perceptions, Australian health policy, highlighting newly accessible 2005 Cabinet papers and what they reveal about PBS reforms, generic pricing, pharmacy agreements and the influence of central agencies like Finance. They warn that today’s reviews, statutory pricing and cost-recovery debates must be viewed as an interconnected agenda. …

Subscribe now to continue reading.

The 'Dispatched' Podcast - Episode 1, Series 5

This is a preview of subscriber content

Latest Video

Most Read

What is it with this organisation's obsession with pharmacy and Europe?

Mesoblast reports strong cell therapy revenue as first year as uptake grows

Pharmacy Guild rejects Grattan Institute report, describing community pharmacies as essential health providers

Can GLP-1s be more transformative than AI - one person believes they already are

The age-old argument for supermarket pharmacies misses the point, and the risks

New Stories

Algorae names Nasdaq pharmaceutical chairman to strengthen board

Starpharma raises $32 Million to advance dendrimer cancer programs

Minister recommits to keeping MS medicines on the PBS while awaiting formal advice

Budget outlook now hangs on disability savings, but what about pharmaceuticals

Australian partnership advances gene therapy for Retinitis Pigmentosa

Patients move to reclaim access agenda ahead of sector negotiations

An opportunity to become a global destination for paediatric oncology trials

Sign In

The 'Dispatched' Podcast - Episode 1, Series 5

This is a preview of subscriber content

Latest Video

Most Read

What is it with this organisation's obsession with pharmacy and Europe?

Mesoblast reports strong cell therapy revenue as first year as uptake grows

Pharmacy Guild rejects Grattan Institute report, describing community pharmacies as essential health providers

Can GLP-1s be more transformative than AI - one person believes they already are

The age-old argument for supermarket pharmacies misses the point, and the risks

Follow Us

New Stories

Algorae names Nasdaq pharmaceutical chairman to strengthen board

Starpharma raises $32 Million to advance dendrimer cancer programs

Minister recommits to keeping MS medicines on the PBS while awaiting formal advice

Budget outlook now hangs on disability savings, but what about pharmaceuticals

Australian partnership advances gene therapy for Retinitis Pigmentosa

Patients move to reclaim access agenda ahead of sector negotiations

An opportunity to become a global destination for paediatric oncology trials